The independent prognostic impact, as well as the possible causal role, of hyperhomocysteinemia (HHcy) in coronary artery disease (CAD) is controversial. No previous study specifically has addressed the relationship between HHcy and mortality after coronary artery bypass grafting (CABG) surgery. The aim of this study is to evaluate the prognostic impact of HHcy after CABG surgery.
Hyperhomocysteinemia and Mortality after Coronary Artery Bypass Grafting
GIRELLI, Domenico;MARTINELLI, Nicola;OLIVIERI, Oliviero;PIZZOLO, Francesca;FRISO, Simonetta;BOZZINI, Claudia;TENUTI, Ilaria;LOTTO, Valentina;GUARINI, Patrizia;TRABETTI, Elisabetta;PIGNATTI, Pierfranco;MAZZUCCO, Alessandro;CORROCHER, Roberto
2006-01-01
Abstract
The independent prognostic impact, as well as the possible causal role, of hyperhomocysteinemia (HHcy) in coronary artery disease (CAD) is controversial. No previous study specifically has addressed the relationship between HHcy and mortality after coronary artery bypass grafting (CABG) surgery. The aim of this study is to evaluate the prognostic impact of HHcy after CABG surgery.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
